secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001193125-23-141992
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Teva director Jean-Michel Halfon resigns from board, effective May 8, 2023
--------------------------------------------------------------------------

- Jean-Michel Halfon resigned immediately on May 8, 2023, citing personal reasons.
- He served as a director since 2014, chairing the HR/Compensation and Compliance Committees.
- Halfon was not standing for re-election at Teva's June 15, 2023 annual meeting; no disagreements with Teva.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312523141992/0001193125-23-141992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312523141992/d502794d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-141992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer